Pursuant to Regulation 30 & 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Coral Laboratories has informed that it has enclosed copies of Notice of Board Meeting to be held on 12th November, 2020 to consider and approve unaudited financial results of the quarter and half year ended 30th September, 2020 published in following newspapers: Business Standard(English), Western Times (Gujrati), and Western Times (English) all dated on 05.11.2020.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1658.30 |
| Dr. Reddys Lab | 1219.90 |
| Cipla | 1230.95 |
| Zydus Lifesciences | 931.80 |
| Lupin | 2313.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: